Activation and desensitization of rat A3-adenosine receptors by selective adenosine derivatives and xanthine-7-ribosides

Kyung Sun Park, Carsten Hoffmann, Hea Ok Kim, William L. Padgett, John W. Daly, Roberta Brambilla, Cristina Motta, Maria P. Abbracchio, Kenneth A. Jacobson

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Xanthine and adenosine derivatives, known to bind to recombinant rat A3 adenosine receptors stably expressed in Chinese hamster ovary cells, were characterized in a functional assay consisting of activation of A3 receptor- stimulated binding of [35S]GTPγS in rat RBL-2H3 cell membranes 1,3- Dibutylxanthine-7-riboside-5'-N-methylcarboxamide (DBXRM, 7b), previously shown to inhibit adenylyl cyclase via rat A3 receptors with full efficacy, appeared to be a partial agonist at the rat A3 receptor of RBL-2H3 cells. Full agonists, such as CI-IB-MECA or I-AB-MECA, were more potent and effective than the partial agonist DBXRM in causing desensitization of rat A3 receptors, as indicated by loss of [35S]GTPγS binding. At A1 receptors, antagonism of agonist-elicited inhibition of rat adipocyte adenylyl cyclase was observed for several xanthine-7-riboside derivatives that had been shown to be full agonists at rat A3 receptors. A new xanthine riboside (3'-deoxyDBXRM, 7c) was synthesized and found to be a partial agonist at rat A3 receptors and an antagonist at rat A1 receptors. Thus, it is possible for the same compound to stimulate one adenosine receptor subtype (A3) and block another subtype (A1) within the same species.

Original languageEnglish
Pages (from-to)97-105
Number of pages9
JournalDrug Development Research
Volume44
Issue number2-3
DOIs
StatePublished - Jun 1 1998
Externally publishedYes

Fingerprint

Adenosine A3 Receptors
Xanthine
Adenosine
Rats
Chemical activation
Derivatives
Adenylyl Cyclases
Purinergic P1 Receptors
Cell membranes
Cricetulus
Adipocytes
Ovary
Assays
Cells
Cell Membrane

Keywords

  • Adenosine derivatives
  • Adenylyl cyclase
  • Guanine nucleotides
  • Nucleosides
  • Xanthines

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

Activation and desensitization of rat A3-adenosine receptors by selective adenosine derivatives and xanthine-7-ribosides. / Park, Kyung Sun; Hoffmann, Carsten; Kim, Hea Ok; Padgett, William L.; Daly, John W.; Brambilla, Roberta; Motta, Cristina; Abbracchio, Maria P.; Jacobson, Kenneth A.

In: Drug Development Research, Vol. 44, No. 2-3, 01.06.1998, p. 97-105.

Research output: Contribution to journalArticle

Park, Kyung Sun ; Hoffmann, Carsten ; Kim, Hea Ok ; Padgett, William L. ; Daly, John W. ; Brambilla, Roberta ; Motta, Cristina ; Abbracchio, Maria P. ; Jacobson, Kenneth A. / Activation and desensitization of rat A3-adenosine receptors by selective adenosine derivatives and xanthine-7-ribosides. In: Drug Development Research. 1998 ; Vol. 44, No. 2-3. pp. 97-105.
@article{e84d47ddcdb143138bd742c813e0714a,
title = "Activation and desensitization of rat A3-adenosine receptors by selective adenosine derivatives and xanthine-7-ribosides",
abstract = "Xanthine and adenosine derivatives, known to bind to recombinant rat A3 adenosine receptors stably expressed in Chinese hamster ovary cells, were characterized in a functional assay consisting of activation of A3 receptor- stimulated binding of [35S]GTPγS in rat RBL-2H3 cell membranes 1,3- Dibutylxanthine-7-riboside-5'-N-methylcarboxamide (DBXRM, 7b), previously shown to inhibit adenylyl cyclase via rat A3 receptors with full efficacy, appeared to be a partial agonist at the rat A3 receptor of RBL-2H3 cells. Full agonists, such as CI-IB-MECA or I-AB-MECA, were more potent and effective than the partial agonist DBXRM in causing desensitization of rat A3 receptors, as indicated by loss of [35S]GTPγS binding. At A1 receptors, antagonism of agonist-elicited inhibition of rat adipocyte adenylyl cyclase was observed for several xanthine-7-riboside derivatives that had been shown to be full agonists at rat A3 receptors. A new xanthine riboside (3'-deoxyDBXRM, 7c) was synthesized and found to be a partial agonist at rat A3 receptors and an antagonist at rat A1 receptors. Thus, it is possible for the same compound to stimulate one adenosine receptor subtype (A3) and block another subtype (A1) within the same species.",
keywords = "Adenosine derivatives, Adenylyl cyclase, Guanine nucleotides, Nucleosides, Xanthines",
author = "Park, {Kyung Sun} and Carsten Hoffmann and Kim, {Hea Ok} and Padgett, {William L.} and Daly, {John W.} and Roberta Brambilla and Cristina Motta and Abbracchio, {Maria P.} and Jacobson, {Kenneth A.}",
year = "1998",
month = "6",
day = "1",
doi = "10.1002/(SICI)1098-2299(199806/07)44:2/3<97::AID-DDR7>3.0.CO;2-5",
language = "English",
volume = "44",
pages = "97--105",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",
number = "2-3",

}

TY - JOUR

T1 - Activation and desensitization of rat A3-adenosine receptors by selective adenosine derivatives and xanthine-7-ribosides

AU - Park, Kyung Sun

AU - Hoffmann, Carsten

AU - Kim, Hea Ok

AU - Padgett, William L.

AU - Daly, John W.

AU - Brambilla, Roberta

AU - Motta, Cristina

AU - Abbracchio, Maria P.

AU - Jacobson, Kenneth A.

PY - 1998/6/1

Y1 - 1998/6/1

N2 - Xanthine and adenosine derivatives, known to bind to recombinant rat A3 adenosine receptors stably expressed in Chinese hamster ovary cells, were characterized in a functional assay consisting of activation of A3 receptor- stimulated binding of [35S]GTPγS in rat RBL-2H3 cell membranes 1,3- Dibutylxanthine-7-riboside-5'-N-methylcarboxamide (DBXRM, 7b), previously shown to inhibit adenylyl cyclase via rat A3 receptors with full efficacy, appeared to be a partial agonist at the rat A3 receptor of RBL-2H3 cells. Full agonists, such as CI-IB-MECA or I-AB-MECA, were more potent and effective than the partial agonist DBXRM in causing desensitization of rat A3 receptors, as indicated by loss of [35S]GTPγS binding. At A1 receptors, antagonism of agonist-elicited inhibition of rat adipocyte adenylyl cyclase was observed for several xanthine-7-riboside derivatives that had been shown to be full agonists at rat A3 receptors. A new xanthine riboside (3'-deoxyDBXRM, 7c) was synthesized and found to be a partial agonist at rat A3 receptors and an antagonist at rat A1 receptors. Thus, it is possible for the same compound to stimulate one adenosine receptor subtype (A3) and block another subtype (A1) within the same species.

AB - Xanthine and adenosine derivatives, known to bind to recombinant rat A3 adenosine receptors stably expressed in Chinese hamster ovary cells, were characterized in a functional assay consisting of activation of A3 receptor- stimulated binding of [35S]GTPγS in rat RBL-2H3 cell membranes 1,3- Dibutylxanthine-7-riboside-5'-N-methylcarboxamide (DBXRM, 7b), previously shown to inhibit adenylyl cyclase via rat A3 receptors with full efficacy, appeared to be a partial agonist at the rat A3 receptor of RBL-2H3 cells. Full agonists, such as CI-IB-MECA or I-AB-MECA, were more potent and effective than the partial agonist DBXRM in causing desensitization of rat A3 receptors, as indicated by loss of [35S]GTPγS binding. At A1 receptors, antagonism of agonist-elicited inhibition of rat adipocyte adenylyl cyclase was observed for several xanthine-7-riboside derivatives that had been shown to be full agonists at rat A3 receptors. A new xanthine riboside (3'-deoxyDBXRM, 7c) was synthesized and found to be a partial agonist at rat A3 receptors and an antagonist at rat A1 receptors. Thus, it is possible for the same compound to stimulate one adenosine receptor subtype (A3) and block another subtype (A1) within the same species.

KW - Adenosine derivatives

KW - Adenylyl cyclase

KW - Guanine nucleotides

KW - Nucleosides

KW - Xanthines

UR - http://www.scopus.com/inward/record.url?scp=0031660803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031660803&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2299(199806/07)44:2/3<97::AID-DDR7>3.0.CO;2-5

DO - 10.1002/(SICI)1098-2299(199806/07)44:2/3<97::AID-DDR7>3.0.CO;2-5

M3 - Article

AN - SCOPUS:0031660803

VL - 44

SP - 97

EP - 105

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 2-3

ER -